Back to Journals » Patient Preference and Adherence » Volume 8

Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing–remitting multiple sclerosis treatment

Total article views   HTML views PDF downloads Totals
24,745 Dovepress* 18,262+ 2,087 20,349
PubMed Central* 6,483 1,164 7,647
Totals 24,745 3,251 27,996
*Since 21 August 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 0 6

View citations on PubMed and Google Scholar